183 related articles for article (PubMed ID: 14707087)
1. The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense.
Leemans JC; te Velde AA; Florquin S; Bennink RJ; de Bruin K; van Lier RA; van der Poll T; Hamann J
J Immunol; 2004 Jan; 172(2):1125-31. PubMed ID: 14707087
[TBL] [Abstract][Full Text] [Related]
2. The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells.
Kwakkenbos MJ; Chang GW; Lin HH; Pouwels W; de Jong EC; van Lier RA; Gordon S; Hamann J
J Leukoc Biol; 2002 May; 71(5):854-62. PubMed ID: 11994511
[TBL] [Abstract][Full Text] [Related]
3. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97.
Lin HH; Stacey M; Hamann J; Gordon S; McKnight AJ
Genomics; 2000 Jul; 67(2):188-200. PubMed ID: 10903844
[TBL] [Abstract][Full Text] [Related]
4. Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils.
Stacey M; Lin HH; Hilyard KL; Gordon S; McKnight AJ
J Biol Chem; 2001 Jun; 276(22):18863-70. PubMed ID: 11279179
[TBL] [Abstract][Full Text] [Related]
5. An unusual mode of concerted evolution of the EGF-TM7 receptor chimera EMR2.
Kwakkenbos MJ; Matmati M; Madsen O; Pouwels W; Wang Y; Bontrop RE; Heidt PJ; Hoek RM; Hamann J
FASEB J; 2006 Dec; 20(14):2582-4. PubMed ID: 17068111
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97.
Hamann J; Stortelers C; Kiss-Toth E; Vogel B; Eichler W; van Lier RA
Eur J Immunol; 1998 May; 28(5):1701-7. PubMed ID: 9603477
[TBL] [Abstract][Full Text] [Related]
7. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue.
Kop EN; Kwakkenbos MJ; Teske GJ; Kraan MC; Smeets TJ; Stacey M; Lin HH; Tak PP; Hamann J
Arthritis Rheum; 2005 Feb; 52(2):442-50. PubMed ID: 15693006
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of the EGF-TM7 family members CD97 and EMR2 in lipid-laden macrophages in atherosclerosis, multiple sclerosis and Gaucher disease.
van Eijk M; Aust G; Brouwer MS; van Meurs M; Voerman JS; Dijke IE; Pouwels W; Sändig I; Wandel E; Aerts JM; Boot RG; Laman JD; Hamann J
Immunol Lett; 2010 Apr; 129(2):64-71. PubMed ID: 20167235
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of mouse CD97.
Hamann J; van Zeventer C; Bijl A; Molenaar C; Tesselaar K; van Lier RA
Int Immunol; 2000 Apr; 12(4):439-48. PubMed ID: 10744645
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of the human CD97 EGF-TM7 receptor.
Jaspars LH; Vos W; Aust G; Van Lier RA; Hamann J
Tissue Antigens; 2001 Apr; 57(4):325-31. PubMed ID: 11380941
[TBL] [Abstract][Full Text] [Related]
11. Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells.
Kwakkenbos MJ; Pouwels W; Matmati M; Stacey M; Lin HH; Gordon S; van Lier RA; Hamann J
J Leukoc Biol; 2005 Jan; 77(1):112-9. PubMed ID: 15498814
[TBL] [Abstract][Full Text] [Related]
12. The human EGF-TM7 receptor EMR3 is a marker for mature granulocytes.
Matmati M; Pouwels W; van Bruggen R; Jansen M; Hoek RM; Verhoeven AJ; Hamann J
J Leukoc Biol; 2007 Feb; 81(2):440-8. PubMed ID: 17108056
[TBL] [Abstract][Full Text] [Related]
13. The EGF-TM7 family: a postgenomic view.
Kwakkenbos MJ; Kop EN; Stacey M; Matmati M; Gordon S; Lin HH; Hamann J
Immunogenetics; 2004 Jan; 55(10):655-66. PubMed ID: 14647991
[TBL] [Abstract][Full Text] [Related]
14. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding.
Wobus M; Vogel B; Schmücking E; Hamann J; Aust G
Int J Cancer; 2004 Dec; 112(5):815-22. PubMed ID: 15386373
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
Qian YM; Haino M; Kelly K; Song WC
Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
[TBL] [Abstract][Full Text] [Related]
16. CD97 in leukocyte trafficking.
Hamann J; Veninga H; de Groot DM; Visser L; Hofstra CL; Tak PP; Laman JD; Boots AM; van Eenennaam H
Adv Exp Med Biol; 2010; 706():128-37. PubMed ID: 21618832
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex.
Lin HH; Stacey M; Saxby C; Knott V; Chaudhry Y; Evans D; Gordon S; McKnight AJ; Handford P; Lea S
J Biol Chem; 2001 Jun; 276(26):24160-9. PubMed ID: 11297558
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of bovine CD97: an EGF-TM7 molecule expressed as isoforms.
Eichler W; Stieler JT; Vogel B; Wobus M; Aust G
Mol Immunol; 2004 Jul; 41(8):751-8. PubMed ID: 15234554
[TBL] [Abstract][Full Text] [Related]
19. Analysis of CD97 expression and manipulation: antibody treatment but not gene targeting curtails granulocyte migration.
Veninga H; Becker S; Hoek RM; Wobus M; Wandel E; van der Kaa J; van der Valk M; de Vos AF; Haase H; Owens B; van der Poll T; van Lier RA; Verbeek JS; Aust G; Hamann J
J Immunol; 2008 Nov; 181(9):6574-83. PubMed ID: 18941248
[TBL] [Abstract][Full Text] [Related]
20. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
Hamann J; Vogel B; van Schijndel GM; van Lier RA
J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
